Text Size

A Pilot Observational Clinical Survey: Impacts of Tahitian Noni Juice on the Quality of Life of Patients With Osteoarthritis

This study has been completed.
Sponsor:
Collaborator:
Excellence in Academic Medicine (EAM) Grant
Information provided by:
University of Illinois
ClinicalTrials.gov Identifier:
NCT01070264
First received: February 16, 2010
Last updated: NA
Last verified: February 2007
History: No changes posted
  Purpose

Tahitian Noni Juice (TNJ) made from Morinda citrifolia (noni) fruits may provide a safe adjunctive treatment for osteoarthritis (OA) due to its anti-inflammatory and analgesic properties. In this study the investigators examined whether TNJ was able to improve the symptoms and quality of life (QOL) of OA patients. The investigators also sought to evaluate the tolerability and safety of TNJ.

This was an open label three-month intervention pilot study. Data were collected by pre and post intervention survey as well as laboratory testing. Inclusion criteria were: adults of both sexes aged 40 to 75, with a diagnosis of OA on the hip or knee by their primary care physician, not on prescription medicine for OA, and who were willing to drink 3 oz of TNJ a day.


Condition Intervention
Osteoarthritis
 Dietary Supplement: Noni Juice

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Official Title: A Pilot Observational Clinical Survey: Impacts of Tahitian Noni Juice on the Quality of Life of Patients With Osteoarthritis

Resource links provided by NLM:

MedlinePlus related topics: Osteoarthritis
U.S. FDA Resources

Further study details as provided by University of Illinois:

Primary Outcome Measures:
  • Quality of Life [ Designated as safety issue: No ]

Study Start Date: March 2006
Study Completion Date: February 2007
Primary Completion Date: February 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Noni Juice
This was an open label three-month intervention pilot study. Data were collected by pre and post intervention survey as well as laboratory testing. Inclusion criteria were: adults of both sexes aged 40 to 75, with a diagnosis of OA on the hip or knee by their primary care physician, not on prescription medicine for OA, and who were willing to drink 3 oz of TNJ a day
 Dietary Supplement: Noni Juice
This was an open label three-month intervention pilot study. Data were collected by pre and post intervention survey as well as laboratory testing. Inclusion criteria were: adults of both sexes aged 40 to 75, with a diagnosis of OA on the hip or knee by their primary care physician, not on prescription medicine for OA, and who were willing to drink 3 oz of TNJ a day

  Eligibility

Ages Eligible for Study:   40 Years to 75 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • adults aged 40 to 75 of both sexes with a physician diagnosis of OA of the hip or knee who were not taking prescription medicine for arthritis and were willing to drink 3 oz of TNJ daily for 12 weeks

Exclusion Criteria:

  • all others
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01070264

Locations
United States, Illinois
University of Illinois-Chicago College of Medicine at Rockford
Rockford, Illinois, United States, 61107
Sponsors and Collaborators
University of Illinois
Excellence in Academic Medicine (EAM) Grant
  More Information

No publications provided

Responsible Party: Mian-Ying Wang, University of Illinois-Chicago College of Medicine at Rockford
ClinicalTrials.gov Identifier: NCT01070264     History of Changes
Other Study ID Numbers: 20050074
Study First Received: February 16, 2010
Last Updated: February 16, 2010
Health Authority: United States: Institutional Review Board

Keywords provided by University of Illinois:
Osteoarthritis

Additional relevant MeSH terms:
Osteoarthritis
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases

ClinicalTrials.gov processed this record on May 16, 2013